Expression of hepcidin, a central regulator of systemic iron metabolism, is transcriptionally regulated by the bone morphogenetic protein (BMP) pathway.
Introduction
Iron is essential for fundamental metabolic processes in cells and organisms. Iron homeostasis is strictly maintained through cellular and systemic systems. Cellular iron metabolism is regulated through iron-regulatory proteins that bind iron-responsive elements in regulated mRNAs. By contrast, systemic iron metabolism is mainly governed by the synthesis and secretion of the iron-regulating hormone hepcidin.
Hepcidin is produced by liver parenchymal cells and orchestrates systemic iron fluxes and decreases plasma iron levels by binding to and degrading the iron exporter ferroportin on the surface of iron-releasing cells, especially on the basolateral membrane of enterocytes Hentze et al., 2010; Anderson et al., 2012) .
Hepcidin expression is transcriptionally regulated; bone morphogenetic protein (BMP), a member of the transforming growth factor-β (TGF-β) family, potently stimulates the process (Muckenthaler, 2008; Lee and Beutler, 2009; Hentze et al., 2010; Finberg, 2013) . Members of the TGF-β family, including BMP, TGF-β, and activin, elicit their activities through similar but distinct signal transduction pathways. Upon ligand binding, the receptor complexes phosphorylate carboxyl-terminal serines of receptor-regulated (R-) Smad; BMP induces the phosphorylation of Smad1/5/8, whereas TGF-β/activin do Smad2/3 phosphorylation. Phosphorylated R-Smad forms complexes with the common Smad, Smad4, and these translocate into the nucleus where they participate in the regulation of gene transcription (Miyazono et al., 2010; Massague, 2012; Sakaki-Yumoto et al., 2013) .
In addition to the BMP pathway, several other molecules, such as interleukin (IL)-6, IL-22, oncostatin M and testosterone, also regulate hepcidin transcription (Nemeth et al., 2003; Kanda et al., 2009; Chung et al., 2010; Guo et al., 2013; Smith et al., 2013) ; other factors and mechanisms that regulate hepcidin expression have not yet been fully elucidated.
During the exploration of BMP-induced hepcidin expression, we noticed that serum starvation down-regulates hepcidin expression in hepatocytes. This observation prompted us to pursue the role of serum as a positive regulator in hepcidin expression.
Here we show that serum stimulates hepcidin transcription via the following: an activator protein (AP)-1 binding site within the hepcidin promoter, which spans nt -133 to nt -127 and was identified previously but was not characterized (Truksa et al., 2007) ; the signal transducers and activator of transcription (STAT)-binding site (STAT-BS), which spans nt -143 to nt -134; and the BMP response element 1 (BMP-RE1), which spans nt -155 to nt -150. Although serum treatment does not stimulate the BMP pathway, the basal BMP activity is indispensable for serum-induced hepcidin transcription. In addition, the AP-1 components c-fos and junB induced by serum treatment would be involved in the transcriptional activation. The present study extends our understanding of hepcidin expression. AP-1 is induced by various stimuli, such as stress, infections and inflammations, and certain stimuli that are mediated by cytokines and growth factors (Hess et al., 2004) . Thus, the present results suggest that hepcidin is regulated by more factors than were previously considered.
Materials & methods

RNA isolation and RT-quantitative PCR
Total RNA was isolated from rat primary hepatocytes by using TRIZOL (Invitrogen, Grand Island, NY, USA) and cDNA was synthesized by the ABI high capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA, USA), according to the manufacturers' protocols. The cDNA that was reverse-transcribed from 5 ng of total RNA was used as a template for RT-quantitative PCR (RT-qPCR) as previously described (Asano et al., 2013) . The oligonucleotide primers for RT-qPCR are as follows:
5'-gatggcactcagcactgga-3' and 5'-gctgcagctctgtagtctgtct-3' for hepcidin, 5'-gaacactggatggacgactg-3' and 5'-acagacgggcatagatcaca-3' for Smad4, and 5'-cgtgttcctacccccaatgt-3' and 5'-tgtcatcatacttggcaggtttc-3' for glyceraldehyde-3-phosphate dehydrogenase (Gapdh). The Ct value was determined, and the abundance of gene transcripts was analyzed using the ∆∆Ct method and by normalizing against the Gapdh gene (Duran et al., 2005) .
Western blot
Western blot analyses were performed as previously described (Funaba and Murakami, 2008) . The immunoreactive proteins were visualized using the ECL Select Western blotting detection system (GE Healthcare, Buckinghamshire, UK) according to the manufacturer's protocol.
Plasmids
The DNA sequence that spans nt -2018 to nt -35 of the mouse hepcidin (Hamp1) promoter was amplified and cloned into a pGL4 basic vector that contained the firefly luciferase reporter (Hepcidin (-2018)-luc); nt +1 was defined as the translation initiation site. Reporter plasmids with deleted promoters or point mutations were prepared by a PCR-based method. The dominant negative (dn)-c-fos, which lacks region encoding amino acid 133 to amino acid 159 (Ransone et al., 1990) , was also prepared by a PCR-based method. The plasmids were verified by DNA sequencing. Expression vectors for c-fos, junB and dn-jun B were kindly provided by Dr. M. Hibi.
Reporter assays
HepG2 and Hepa1-6 hepatoma cells were transiently transfected with the described expression vectors, reporter construct and a plasmid expressing β-galactosidase were cultured with medium with or without heat-inactivated FBS for 24 h. Luciferase activity in the cell lysate was normalized to β-galactosidase activity.
Statistical analyses
Data are expressed as the mean ± standard error (SE). Data on gene expression were log-transformed to provide an approximation of a normal distribution before analysis.
Differences between gene expression in the cells were examined using unpaired t-tests.
Differences of P < 0.05 were considered significant.
Results and discussion
Serum stimulates hepcidin transcription in liver cells
When effects of exogenous ligand are examined, cells are typically cultured with a reduced concentration of heat-inactivated FBS before and during ligand stimulation.
During the analysis of BMP-induced hepcidin expression in rat primary hepatocytes, we reproducibly observed that serum starvation itself down-regulates hepcidin expression significantly (P < 0.05, Fig. 1A ). The decreased expression levels of hepcidin were not caused by a non-specific down-regulation of gene expression, because serum starvation did not affect Smad4 expression. These results suggest that serum has a stimulatory effect on hepcidin expression. Thus, we aimed to verify the up-regulation of hepcidin expression levels in response to serum treatment. Attached rat primary hepatocytes were cultured in the absence of heat-inactivated FBS followed by treatment with or without 10% FBS. Consistent with the results on the effects of serum starvation (Fig. 1A) , the serum treatment clearly increased expression of hepcidin but not Smad4 in primary hepatocytes (P < 0.01, Fig. 1B ).
Previous studies revealed that hepcidin expression is primarily increased by activation of the BMP pathway Hentze et al., 2010; Finberg, 2013) .
Especially, BMP6 principally regulates hepcidin transcription in livers; mice lacking BMP6 exhibited inappropriately low level of hepcidin and massive iron overload (Andriopoulos et al., 2009; Meynard et al., 2009) . BMP2 is relatively heat-stable, and heat-inactivation of FBS for 30 min at 56°C did not decrease the bioactivity of BMP2 (Ohta et al., 2005) , although the stability of BMP6 in response to the heat treatment is unknown. Thus, it is possible that BMP or the related molecule(s) in heat-inactivated FBS is responsible for serum-induced hepcidin expression. To this end, we evaluated phosphorylated Smad1/5/8 in response to serum stimulation in primary hepatocytes because BMPs elicit their activities through the phosphorylation of carboxyl-terminal serines of Smad1/5/8 (Miyazono et al., 2010; Massague, 2012; Sakaki-Yumoto et al., 2013) .
Serum treatment did not increase the phosphorylation levels of Smad1/5/8 in primary hepatocytes; rather, phosphorylated Smad1/5/8 levels tended to decrease with serum treatment, implying the presence of inhibitor(s) for the BMP pathway in serum (Fig. 1C , lanes 2-9). As expected, Smad1/5/8 was clearly phosphorylated within 1 h after BMP2 treatment in primary hepatocytes (Fig. 1C , lanes 10 and 11). Pre-treatment with LDN-193189 decreased phosphorylation levels of Smad1/5/8 ( Fig. 1D ) and abrogated serum-induced hepcidin expression ( Fig. 1E ).
To explore serum-induced hepcidin expression in detail, experiments were next performed in HepG2 cells and Hepa1-6 cells. Consistent with the results from primary hepatocytes, serum treatment did not induce the phosphorylation of Smad1/5/8 in either
HepG2 cells or Hepa1-6 cells ( Fig. 2A ). We next examined hepcidin transcription by luciferase-based reporter assays in HepG2 cells and Hepa1-6 cells; these cell lines are suitable to examine hepcidin transcription but not hepcidin expression at the mRNA level (Kanamori et al., 2014) . Serum treatment increased the expression levels of hepcidin(-2018)-luc in HepG2 cells and Hepa1-6 cells ( Fig. 2B ), which indicated that serum-induced hepcidin expression is regulated at the level of transcription. In addition, pre-treatment with LDN-193189 decreased luciferase activity and blocked serum-induced hepcidin transcription (Fig. 2B ). These results indicate that BMP activity is not further enhanced by serum treatment but that endogenous BMP activity is required for serum-induced hepcidin expression and transcription in liver cells.
We also evaluated effects of BMP6 in heat-inactivated FBS on Smad1/5/8 phosphorylation and hepcidin transcription in HepG2 cells and Hepa1-6 cells. Herrera and Inman (2009) revealed that a BMP concentration greater than 100 pM is required to induce hepcidin expression (Truksa et al., 2006; Maes et al., 2010; Wu et al., 2012) .
Serum-induced hepcidin transcription is mediated via BMP-RE1, TRE and STAT-BS
Previous studies revealed that the hepcidin promoter has two BMP responsive elements:
BMP-RE1 (spanning nt -155 to nt -150) and BMP-RE2 (spanning nt -1678 to nt -1673) (Casanovas et al., 2009; Truksa et al., 2009) . We performed reporter assays using a series of deleted reporters of mouse hepcidin promoter. The responsiveness to serum treatment was still detected by a deletion of BMP-RE2, although basal transcription was reduced and the extent of the increase in luciferase expression in response to serum treatment was decreased (Fig. 3A) . The deletion of BMP-RE1 further decreased basal transcription and inhibited the responsiveness to serum treatment (Fig. 3A) , which suggests an essential role of BMP-RE1 in serum-induced hepcidin transcription.
Consistent with these results, reporter assays that used reporters with point mutations in BMP-RE1, BMP-RE2 or both revealed that serum-induced hepcidin transcription was inhibited in reporters containing mutations in BMP-RE1 but not BMP-RE2 (Fig. 3B ).
Serum treatment is known to induce the expression of AP-1 components, which stimulate transcription by binding to the TPA-responsive element (TRE) located in the transcriptional regulatory region of the gene (Shaulian and Karin, 2002; Hess et al., 2004) . The TRE consensus sequence is TGA G /CTCA (Shaulian and Karin, 2002; Hess et al., 2004) , but the closely related sequence TGAGACA also binds to AP-1 and confers AP-1-mediated transcription (Kim et al., 1990) . A search for the hepcidin gene identified a possible TRE sequence from nt -133 to nt -127 ( Fig. 4A ). Truksa et al. (2007) reported the existence of the TRE sequence in the hepcidin gene and explored its function in IL-6 and BMP9-induced hepcidin transcription by using a reporter plasmid containing the hepcidin promoter with TRE mutations. However, to create the "TRE mutated reporter" they mutated sequence outside of the core TRE sequence (TGA G /CTCA) (Truksa et al., 2007) , and therefore the role of TRE was not strictly evaluated in their study. Additionally, adjacent to the TRE sequence, a STAT-BS sequence spans nt -143 to nt -134 ( Fig. 4A ). Although the STAT-BS sequence has been reported to function in IL-6-induced transcription (Wrighting and Andrews, 2006) , mutations in the STAT-BS in mouse hepcidin (Hamp1) did not affect the responsiveness to IL-6 (Truksa et al., 2007) . In the present study, we prepared reporter plasmids with mutated core TRE sequence (mTRE), STAT-BS sequence (mSTAT) or both (mSTAT, TRE) by introducing point mutations at distal sites from the mutual elements ( Fig. 4B ).
In this case, we used a reporter plasmid with a shorter hepcidin promoter, hepcidin(-270)-luc, as a wild-type plasmid to evaluate serum responsiveness (Fig. 3A ). -292 to nt -283, as a putative AP-1 binding site (Fig. 5A ). Nevertheless, we examined the role of the region spanning from nt -292 to nt -283 by use of hepcidin(-581)-luc as a wild-type plasmid. The responsiveness to serum was not changed by the mutations of the region (Fig. 5B) . The results are consistent with those that deletion of nt -581 to nt 271 did not affect hepcidin transcription in response to serum (Fig. 3A) . Thus, we conclude that the putative AP-1 site suggested by Verga Falzacappa et al. (2007) is not functional for serum-induced transcription of mouse hepcidin.
Serum
Serum induces c-fos and junB expression in liver cells, which is responsible for hepcidin transcription via TRE and STAT-BS
We examined the induction of AP-1 in response to serum treatment in primary hepatocytes ( Fig. 6A ) and HepG2 cells (Fig. 6B) . The time-course changes that occurred during serum stimulation were similar between the two cell types but were different among the genes analyzed; c-fos expression was transiently induced within 30 min after serum treatment, and c-fos expression levels returned to basal levels at 1.5 h after serum treatment in primary hepatocytes and at 2 h in HepG2 cells. Expression levels of junB significantly higher in cells treated with serum at 1 h of serum treatment in primary hepatocytes and from 0.5 h to 4 h in HepG2 cells. In contrast, serum treatment did not significantly affect c-jun expression in primary hepatocytes, although it slightly but significantly increased from 0.5 to 4 h in HepG2 cells.
Considering that serum treatment stimulated hepcidin expression and transcription in primary hepatocytes and HepG2 cells, expression of c-fos and junB but not c-jun may be involved in serum-induced hepcidin transcription. Thus, we explored the effects of the forced expression of c-fos and junB were examined (Fig. 7) . Expression of c-fos alone increased transcription of hepcidin, and it also increased serum-induced hepcidin transcription. The responsiveness to serum also increased with junB expression, although junB expression alone did not stimulate hepcidin transcription. Mutations of either the STAT-BS or TRE sequences decreased hepcidin transcription, irrespective of serum stimulation. The effects of the TRE mutations were more remarkable, but the reporters still responded to serum treatment. Double mutations in both the STAT-BS and TRE sequences completely inhibited hepcidin transcription.
We further examined effects of expression of dn-c-fos or dn-junB on hepcidin transcription (Fig. 8 ). Basal transcription of hepcidin was decreased by expression of dn-c-fos or dn-junB. In addition, the extent of the increase in luciferase activity in response to serum treatment was smaller in cells expressing dn-c-fos or dn-junB than in those expressing empty vector.
Here, we showed that withdrawal of heat-inactivated FBS decreased the expression of hepcidin in primary hepatocytes and that serum treatment increased hepcidin expression and transcription (and vice versa) in primary hepatocytes, HepG2 cells and Hepa1-6 cells. We also demonstrated that serum treatment does not stimulate the BMP pathway To clarify the role of AP-1 in BMP signaling, the effects of exogenous BMP should be examined in future studies.
During the preparation of this manuscript, the effect of serum treatment on hepcidin transcription was reported (Shanmugam and Cherayil, 2013) . These researchers showed that heat-inactivated FBS treatment increased the phosphorylation levels of Smad1/5/8 and hepcidin mRNA levels in HepG2 cells, which were blocked by co-treatment with dorsomorphin, an inhibitor of the BMP type I receptor, as well as AMPK (Zhou et al., 2001; Yu et al., 2008b) . These authors concluded that BMP or BMP-related proteins in heat-inactivated FBS are responsible for the serum-induced hepcidin mRNA changes, and these researchers' results on serum-induced hepcidin expression are consistent with those of the present study. However, the underlying mechanism clearly contrasts with our results; the reason for this inconsistency is currently unknown. Luciferase activity was normalized to β-galactosidase activity, and the luciferase activity in cells that were cultured in the absence of FBS and were transfected with hepcidin(-270)-luc was set to 1. Data were expressed as the mean ± SE from a representative experiment (n = 3). h followed by culturing with or without 10% heat-inactivated FBS for 24 h. Luciferase activity was normalized to β-galactosidase activity, and the luciferase activity was set to 1 in cells that were cultured in the absence of exogenous AP-1 components and FBS and were transfected with hepcidin(-270)-luc. Data were expressed as the mean ± SE from a representative experiment (n = 3). heat-inactivated FBS for 24 h. Luciferase activity was normalized to β-galactosidase activity, and the luciferase activity was set to 1 in cells that were cultured in the absence of exogenous AP-1 components and FBS and were transfected with hepcidin(-270)-luc.
Figure legend
Data were expressed as the mean ± SE from a representative experiment (n = 3). 
